Latest news

Thumbnail image for New breast cancer testing tool in development

New breast cancer testing tool in development

A study carried out by researchers from the University of Cambridge, National Cancer Institute, National Institutes of Health in the US among others has shown how putting different genetic and risk factor data into a prediction equation could help us understand how likely a woman is to develop breast cancer.

16th January 2019

Thumbnail image for Keytruda reduces risk of death compared to chemo

Keytruda reduces risk of death compared to chemo

Merck’s Keytruda has been found to reduce risk of death by 31% compared to chemotherapy, when used in previously treated patients with advanced esophageal or esophagogastric junction carcinoma, whose tumours express PD-L1.

15th January 2019

Thumbnail image for Health Canada restricts Allergan's Esmya

Health Canada restricts Allergan's Esmya

Health Canada has placed restrictions on Allergan's uterine fibroid treatment Esmya, after discovering a possible link between its use and the risk of a rare but serious liver injury.

15th January 2019

Thumbnail image for PreP Impact trial to double in size

PreP Impact trial to double in size

Speed of recruitment and demand for a trial assessing the impact of HIV prevention therapy PrEP has significantly exceeded initial predictions, leading researchers to consider increasing the number of participants from 13,000 to up to 26,000.

14th January 2019

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download